But : Déterminer les aspects épidémiologiques, étiologiques, thérapeutiques et évolutifs de la gangrène de Fournier. Patients et Méthodes : Il s'agissait d'une étude rétrospective et descriptive portant sur 10 patients ayant été traités dans quatre principaux hôpitaux publics de Bujumbura pour Gangrène de Fournier. Elle s'étend sur une période de deux ans. Résultats : La fréquence de la GF était de 0,102%. L'âge moyen était de 46,7 ans. Tous nos patients étaient masculins. Six malades sur 10 avaient consulté entre 5 et 15 jours après le début des signes. Les antécédents urogénitaux prédominent (40%). Les facteurs favorisants étaient le diabète (40%), la paraplégie (20%) et le VIH (10%). La GF secondaire représentait 7 cas dont 4 urogénitales, 2 cutanées et 1 proctologique. Les lésions se limitaient au périnée chez 80% des malades. L'examen bactériologique retrouvait l'Escherichia Coli (70%). Tous les décès (2 cas) avaient un ISGF de 10,5. L'association céphalosporine, aminoside et imidazole était principalement prescrite (60%). Le traitement chirurgical était essentiellement le débridement (90. La dérivation urinaire était faite chez tous les malades. Un séjour moyen était 93,6 jours. Les complications retrouvées étaient choc septique (20%), insuffisance rénale (40%) et anémie (20%). Conclusion : La GF reste une pathologie relativement rare. La consultation tardive explique le retard diagnostique. Les étiologies sont dominées par les causes urogénitales avec le diabète comme facteur de risque principal. La consultation précoce et le contrôle des facteurs favorisant réduiraient le taux de mortalité.

Aim: There were no data about esophageal cancer in Burundi. The aim of the study was to highlight the epidemiological, clinical and histopathological aspects of the esophageal cancer. Method: A retrospective study over a 24-years period (from January 1988 to December 2011) was carried out at Kamenge university hospital, including patients with esophageal cancer. The cases were selected on basis of the histological evidence of the cancer. Results: A total of 34 cases were retrieved and included for analysis. Among them, 24 patients (70.5%) were males. The esophageal cancer constituted 8.6% of digestive cancers over the period of the study. The average age was 50.9 years. It was revealed by dysphagia in 32 patients (94.1%) and was concomitantly metastatic in 12 patients. The squamous cell carcinoma was 30 cases (88.2%). 27 patients underwent a curative resection, but the outcome and prognosis were poor. In-hospital mortality and morbidity rates were respectively 8.8% and 17.7%. Conclusion: The present study showed evidence that the esophageal cancer in our country had the same characteristics and distribution as well as in developing countries. It had a poor prognosis and efforts had to be done in the early cancer detection.

Colorectal cancer is a major cause of morbidity and mortality throughout the world. There is no study about colorectal cancer in our country. The aim of the study was to assess epidemiological, clinical, therapeutic and histological aspects of colorectal cancer over a 10-year period (1999-2008) in Kamenge university hospital, Bujumbura, Burundi, by a descriptive retrospective study. A total of 37 cases of colorectal cancer, 22 males (59.5%) and 15 females (40.5%), mean age 50.8 years, were retrieved over the period of the study. The colorectal cancer was revealed by a rectal bleeding in 21 patients (56.8%) and an occlusive syndrome in 5 patients (13.5%). All patients underwent surgery. According to Dukes' stages: 27% were A, 27% B, 19% C and 27% stage D. Histopathologically, 18 cases (46.7%) were differentiated adenocarcinoma, 14 cases (37.8%) undifferentiated adenocarcinoma, 2 cases of lymphoma and 2 cases of leiomyosarcoma. All patients underwent surgery. The hospitalization stay was a mean of 27 days. The prognosis was poor with a mortality rate of 13.5% in the hospital. In conclusion, colorectal cancer deserves awareness as a public health problem in our country.

No abstract

No abstract